Loading fund overlap…
13 of 113 unique stocks in common · Jaccard: 11.5%
A weighted portfolio overlap of 20.15% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹20.15 is allocated to the exact same companies at the same relative proportions. The schemes share 13 common holdings.
The largest overlapping asset in their portfolios is Reliance Industries, which commands a weight of 4.65% in Nippon India Nifty India Manufacturing Index Fund and 7.83% in UTI Nifty 50 Index Fund. Holding both schemes increases your concentration in Reliance Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Nippon | in UTI |
|---|---|---|
| Reliance IndustriesPetroleum Products | 4.65% | 7.83% |
| Mahindra & MahindraAutomobiles | 5.12% | 2.66% |
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 4.86% | 1.91% |
| Maruti Suzuki IndiaAutomobiles | 4.08% | 1.60% |
| Tata SteelFerrous Metals | 3.52% | 1.38% |
| Bharat ElectronicsAerospace & Defense | 3.43% | 1.35% |
| Hindalco IndustriesNon - Ferrous Metals | 3.40% | 1.33% |
| Bajaj AutoAutomobiles | 3.10% | 1.22% |
| JSW SteelFerrous Metals | 2.83% | 1.11% |
| Eicher MotorsAutomobiles | 2.53% | 0.99% |
| CiplaPharmaceuticals & Biotechnology | 1.83% | 0.72% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 1.63% | 0.64% |
| Tata Motors Passenger VehiclesAutomobiles | 1.49% | 0.59% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on Aug 2026). Equity holdings only, ISIN-verified. Not investment advice.